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An instrument evaluation ofthe Olympus A U5061 was conducted
by a National Committee on Clinical Laboratory Standards
(NCCLS, 771 East Lancaster Avenue, Villanova, Pennsylvania
19085, USA) protocol. Reagents having the same lot number were
obtainedfrom Data Medical Associates, Inc. (2016 Easl Randol
Mill Road, Arlington, Texas 76011, USA). Formulations
employed were those generally accepted as standard clinical
chemistry methods. Control materials from Dade (American
Hospital Supply Corporation, P. O. Box 520672, Miami, Florida
33152, USA) were analysed to determine within-run and
day-to-day precision. Within-run precision CV) was in the range
of0"31"4"6% for all methods andjudged to be better than that of
the SMAC H Technicon Instruments, Tarrytown, New York
10591, USA). Linear ranges were equal or exceeded those available
on the SMAC H. Of particular importance, the triglycerides
method is linear up to 1000 mg/dl. Recovery studies demonstrated
good recovery for all methods. Carry-over experiments did not
demonstrate evidence ofsignijqcant carry-over. Precision problems
encountered with the bicarbonate, chloride and calcium methods
were resolved by modifying the maintenance procedure. Throughput
assessment demonstrated a maximum throughput of280 specimens/
h and an average throughput of 265 specimens/h. Signifcant
savings in supplies over that required with the continuous jlow
analysers are achievable. Operator training is easily accomplished.
A daily start-up routine requires approximately I h to complete and
makes the instrument relatively easy to place it into test production.
Based upon the consistency of the analytical results obtained, its
aemonstrated throughput of 265 patient profles/h, its ease of
operation and the savings in operating expenses that are possible
with the instrument, the A U5061 was judged to be an effective
replacement for the SMAC H analyser.
Materials
Quality-control materials
Control material was obtained from Dade (American
Hospital Supply Corporation, P.O. Box 520672, Miami,
Florida 33152, USA). Monitrol I (Lot number XLS-37)
and Monitrol II (Lot number XPS-128), which arc
unassayed lyophilized serum control materials were used
for all precision measurements.
Calibrators
A 145/5"0 mmol/1 aqueous standard containing lithium
(3 mmol/1) as an internal standard was supplied by
Olympus and used to calibrate the flame photometer. Set
Point (Lot number V6B258) and Set Point 2 (Lot
number V6C261) from Technicon (Technicon Instru-
ments Corporation, 511 Benedict Avenue, Tarrytown,
New York 10591, USA) and the values supplied by
Technicon were used to calibrate all other methods.
New England Reagent Laboratory (NERL) Standards
Weighed-in standards obtained from NERL (14 Almeida
Avenue, East Providence, Rhode Island 02914, USA)
were used to measure linearity for all chemistry proce-
dures except the enzymes. For the latter, Multi-Enzyme
Lin-Trol (PN M2266) was obtained from Sigma (Sigma
Chemical Company, P.O. Box 14508, St Louis, Missouri
63171, USA) and diluted to obtain multiple points. For
bilirubin, cholesterol, triglycerides, GGT and CK dilu-
tions of a high patient serum were used to measure the
linear response of these methods.
Patient samples
Patient samples which had been submitted to SKBL-
Tampa for routine chemistry analysis were used for
estimates of production capacity.
Propane gas
A special grade (99"5%) of propane gas was obtained
from Bishop Welding Supply, Tampa, Florida and a 100
pound (net weight) tank was located outside the building
to meet fire-code and safety requirements.
Deionized water
Laboratory grade deionized water was used throughout
and was supplied by the in-house reverse osmosis/deion-
ized water system.
Chemistry reagents.
All reagents were supplied by Olympus and manufac-
tured by DMA (Data Medical Associates, Inc., 2016 East
Randol Mill Road, Arlington, Texas 76011, USA).
Methods
Guidelines for clinical laboratory instrumentation evalu-
ations followed those specified by National Committee on
Clinical Laboratory Standards (NCCLS) [1-3].
Chemistry methods
All methods employ bichromatic measurements. The
chemical basis for each method summarized below is
taken from Olympus AU5000 application sheets [4]:
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(1) Na/K: Flame photometry; lithium (3 mmol/1) is
used as an internal standard and flame colour is
measured at 589 nm (Na), 768 nm (K) and 671 nm
(Li).
(2) Glucose: Hexokinase/G-6PDH coupled reaction;
reduction of NAD is used to monitor the reaction
bichromatically at 340/380 nm.
(3) Chloride: Mercuric thiocynate/ferric nitrate; colour
is measured bichromatically at 520/600 nm.
(4) BUN: Urease/alpha-ketoglutarate; the oxidation
of NADH to NAD+ is measured bichromatically at
340/410 nm.
(5) Creatinine: Sodium picrate; colour is measured
bichromatically at 520/600 nm.
(6) Uric acid: Uricase/peroxidase coupled reaction;
colour of complex produced is measured bichromati-
cally at 520/600 nm.
(7) Calcium: Cresolphthalein complexone and
8-hydroxyquinoline; colour is measured bichromati-
cally at 570/600 nm.
(8) Inorganic phosphorus: Ammonium molybdate and
sulfuric acid; unreduced phosphomolybdate complex is
measured bichromatically at 340/380 nm.
(9) Total protein: Modified biuret reaction; colour of
chromagen produced is measured bichromatically at
540/660 nm.
(10) Albumin: Bromcresol green at pH 4’2; colour is
measured bichromatically at 600/750 nm.
(11) Total bilirubin: Formation of azobilirubin with 2,5
dichlorophenyldiazonium (2,5 DCPT); colour is
measured bichromatically at 540/660 nm.
(12) Alkaline phosphatase: Substrate is p-nitrophenyl-
phosphate in 2-amino-2-methyl-l-propanol; rate of
reaction in the presence of magnesium is measured
bichromatically at 410/520 nm.
(13) Lactate dehydrogenase: Substrate is lithium L-lac-
tate; rate ofreduction ofNAD to NADH is measured at
340/410 nm.
(14) AST (GOT): Substrate is L-asparate/2-ketogluta-
rate, coupling with radiate dehydrogenase (MDH);
oxidation of NADH to NAD is measured at 340/410
nm.
(15) ALT (GPT): Substrate is L-alanine/2-ketogluta-
rate, coupling with lactate dehydrogenase (LD); oxida-
tion ofNADH to NAD is measured bichromatically at
340/410 nm.
(16) Triglyceride: Enzymatic coupling with lipase, glye-
rol kinase (GK), glycerol phosphate oxidase (GPO)
and peroxidase (POD); 4 amminoantipyrine and
3-hydroxy-2,4,6-tribomobenzoic acid (TBHB) form a
chromagen and colour is measured bichromatically at
540/600 nm.
(17) Cholesterol: Enzymatic coupling with cholesterol
esterase, cholesterol oxidase and peroxidase; 4-ami-
noantipyrine and 3,4 dichlorophenol form a chro-
magen (quimoneimine) and colour is measured bichro-
matically at 520/750 nm.
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(18) Gamma Glutamyl Transferase (GGT): Substrate is
gamma-glutamyl-p-nitroanilide in glycylglycine; reac-
tion rate is measured bichromatically at 410/520 nm.
(19) Creatine kinase (CK): Substrate is creatine phos-
phate, coupling with hexokinase and glucose-6-phos-
phodehydrogenase; rate of reaction is measured bich-
romatically at 340/520 nm. N-acetyl-L-cysteine (NAC)
is included in the substrate formulation.
(20) Iron: Complex formation using 2,4,6 tripyridyl-s-
triazine; colour is measured bichromatically at 600/750
nm.
Precision study
The precision studies were conducted using two levels of
control material. Within-run precision was determined
from a set of 30 data points. Mean, standard deviation
and coefficient of variation were calculated for each test.
Day-to-day precision was determined for two 10-day sets
and for the 20-day period overall.
Linearity study
The linearity of each method was assessed using either
weighed-in standards obtained from New England
Reagent Laboratory (NERL), or, in the case of the
enzymes, cholesterol, triglycerides and bilirubin, pooled
patient sera. Multiple points throughout the dynamic
range were measured.
Carry-over experiment
In this experiment, 10 separate aliquots of the high and
low controls were sampled to determine a random mean
value for each control. This was compared to the
carry-over mean value obtained for each. The latter was
determined by alternating the sampling ofthe controls. A
carry-over percentage was calculated as follows:
Carry-over (%)
Random mean Carry-over mean
100
Random mean
Correlation study
Patient specimens (N 30) were included in calculating
correlation coefficients using the method of least squares.
Values obtained on the SMAC II were compared to those
obtained on the Olympus AU5061.
Table 1. Olympus AU 5000 series ofchemistry analysers. *
Number of
Model channels Samples/h Tests/h
AU 5031 24 150 3600
AU 5041 32 150 4800
AU 5061 24 300 7200
AU 5081 ** 32 300 9600
* Manufacturer’s specifications.
** Not available to the US market.
Note: Addition of the flame photometer for Na/K increases the
number of channels (tests) by 2.P. B. Hodgin et al. Evaluation of the Olympus AU5061
Table 2. Within-run precision control I.
Test N Mean SD
Range
Variance CV. (%) Min. Max.
Glucose 30 81.60 0.71
Sodium 30 150" 13 0"62
Potassium 30 7"02 0"06
Chloride 30 107"07 0"73
Bicarbonate 30 22"77 0"92
BUN 30 15"93 0"25
Creatinine 30 1" 14 0’05
Uric Acid 30 5"34 0"06
Calcium 30 9"30 0.15
I. Phosphorus 30 2"90 0
T. Protein 30 7"23 0"06
Albumin 30 4"29 0"02
Bilirubin 30 1"23 0"05
Alk. Phos. 30 49"80 0"54
LDH 30 102"67 1"37
AST 30 35"73 0’44
ALT 30 21"47 0"50
Cholesterol 30 239-83 1.19
Triglyceride 30 85"60 1"25
Iron 30 232"37 3"39
GGT 30 15.53 0"72
CK 30 157.13 2"72
0"51 0"87 80 83
0-38 0"41 148 152
0"004 0"80 6-9 7-1
0"53 0"68 106 108
0"85 4"04 21 24
0"06 1"57 15 16
0"002 4"24 1’1 1"2
0"003 1"05 5"2 5"4
0"022 1"58 9"0 9"7
0 0 2"9 2"9
0’004 0"87 7" 7"3
0.001 0"58 4"2 4.3
0"002 3"82 1"2 1"3
0"29 1"09 49 51
1.89 1"34 101 105
0"20 1"24 35 36
0"25 2"32 21 22
1.41 0"49 237 241
1"57 1"47 83 87
11.50 1"46 226 244
0-52 4"62 14 17
7"38 1"73 150 162
Table 3. Within-run precision- control H.
Test N Mean SD
Range
Variance CV(%) Min. Max.
Glucose 30 262"47 1"78
Sodium 30 117"07 0’36
Potassium 30 3"90 0.08
Chloride 30 85"67 0"60
Bicarbonate 30 15"23 0"56
BUN 30 51’53 0"62
Creatinine 30 6" 13 0"06
Uric Acid 30 10"64 0"07
Calcium 30 13"01 0’15
I. Phosphorus 30 6"99 0"06
T. Protein 30 5"32 0.04
Albumin 30 3"33 0"05
Bilirubin 30 4"44 0"06
Alk. Phos. 30 234"30 2"79
LDH 30 342"37 4"09
AST 30 157"87 0"85
ALT 30 123-57 2"85
Cholesterol 30 121"60 0"76
Triglyceride 30 180" 10 1.27
Iron 30 102"23 2"11
GGT 30 74"83 1"07
CK 30 568"00 7"24
3’ 18 0’68 258 265
0’13 0"31 116 118
0"007 2"09 3"8 4"0
0"36 0"70 85 87
0"31 3"67 14 16
0"38 1"20 50 52
0"004 1.04 6"0 6"2
0"005 0.67 10"5 10"8
0"024 1.18 12"7 13"4
0"003 0.80 6"9 7"2
0"001 0"70 5"3 5"4
0"002 1’38 3"3 3-4
0-004 1.38 4"3 4"5
7"81 1.19 230 244
16"77 1"20 336 348
0"72 0.543 156 160
8.11 2-30 119 129
0"57 0"62 120 123
1-62 0.71 176 182
4.45 2’06 98 107
1.14 1"43 73 79
52"40 1"27 551 584
Throughput experiment
The instrument was first primed with fresh reagents.
Calibration samples and controls were placed on the
instrument for initial set up and the instrument was
re-calibrated every hour. Quality control samples were
run every 300 patients. The instrument was operated
continuously for a period of 5"3 hours during which 1410
patients were analysed. Four other throughput experi-
ments consisted of from 500 to 600 specimens each.
Results
Within-run precision
Data on within-run precision is summarized in tables 2
and 3. Precision for both levels of control material was
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1-2% or less for most methods. Bicarbonate (4%) was a
notable exception. At low concentrations, creatinine
(4"2%) and bilirubin (3"8%) were somewhat higher than
the other methods. The enzyme measurements showed
remarkably good precision.
Day-to-@ precision
Data on day-to-day precision is summarized in tables 4
and 5. Data was accumulated from 10 runs performed on
20 separate days. Group means were calculated from the
daily means for each oftwo 10-day periods and overall for
Table 4. Day-to-@ precision- control I.
Test N Mean SD
Range
Variance CV(%) Min. Max.
Glucose 20 81"09 1"46
Sodium 20 149"45 1"35
Potassium 20 6"85 0"10
Chloride 20 106"09 1.44
Bicarbonate 20 22"29 1.26
BUN 20 15"88 0"52
Creatinine 20 1"12 0"05
Uric Acid 20 5"30 0" 12
Calcium 20 9.43 0"24
I. Phosphorus 20 2"88 0"06
T. Protein 20 7’23 0" 14
Albumin 20 4.33 0"05
Bilirubin 20 1"23 0"06
Alk. Phos. 20 53"08 2"48
LDH 20 99"24 4"09
AST 20 36.38 1.16
ALT 20 20"62 1.15
Cholesterol 20 237" 13 3"61
Triglyceride 20 84"76 3"99
Iron 20 233"21 4"78
GGT 20 18"21 1"15
CK 20 166"58 10"07
2" 14 1"80 77 84
1"83 0"90 144 154
0"011 1"50 6"6 7"
2"08 1"36 102 110
1"60 5"67 19 25
0"28 3"31 14 18
0"003 4"72 1"0 1"3
0"015 2"32 5"0 5"6
0-056 2"51 8"8 10"1
0"003 1"94 2"5 3"0
0"020 1’94 6"7 7"5
0"002 1’13 4"2 4"5
0"004 5" 15 1" 1"3
6" 13 4"67 49 60
16"71 4"12 92 108
1"36 3"20 33 38
1"32 5"57 18 23
13"03 1"52 225 247
15"90 4"70 78 96
22"87 2"05 221 247
1"33 6"34 15 21
101"40 6"05 150 193
Table 5. Day-to-@ precision- control H.
Test N Mean SD
Range
Variance CV(%) Min. Max.
Glucose 20 263.61 4.05
Sodium 20 116"68 1"01
Potassium 20 3"94 0"07
Chloride 20 85"02 1"28
Bicarbonate 20 16"33 1.16
BUN 20 51"50 0"92
Creatinine 20 6" 15 0" 12
Uric Acid 20 10"82 0"21
Calcium 20 13.17 0"37
I. Phosphorus 20 6"96 0" 11
T. Protein 20 5"36 0"08
Albumin 20 3’39 0"04
Bilirubin 20 4"47 0" 15
Alk. Phos. 20 243"00 6"04
LDH 20 319"53 13"63
AST 20 159"53 3"84
ALT 20 123"34 2"78
Cholesterol 20 121"92 1"42
Triglyceride 20 185"20 12"43
Iron 20 104.47 3"02
GGT 20 76"21 1"28
CK 20 568" 14 15"44
16.44 1"54 253 274
1"03 0"87 113 119
0"006 1"90 3" 7 4"
1.64 1"51 81 87
1"35 7"12 13 18
0.84 1"78 49 53
0"014 "94 5"8 6"4
0"05 "98 10’ 11 "2
0.14 2"84 12"2 14"0
0"011 1"52 6"6 7’2
0"007 1"51 5"2 5"6
0"002 1"24 3"3 3"5
0"021 3"27 4"0 4’8
36"49 2"49 229 258
185"86 4"27 293 348
14.78 2"41 149 170
7"75 2"26 116 131
2"02 1’ 17 117 127
154"62 6"71 165 218
9" 12 2"89 98 113
1"64 1"68 73 80
238"31 2"72 522 593
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the 20-day period. Precision on the bicarbonate proce-
dure improved considerably by introducing a rinse
solution containing hypochlorite. This was also found to
be a necessary step with the chloride and calcium
methods. Day-to-day precision for all methods, including
enzymes, was less than 7%.
Linearity
Linearity of the methods was determined using weighed-
in standards obtained from New England Reagent
Laboratory (NERL), dilutions ofpatient sera, and serum
based materials. These results are summarized in table 6.
The stated dynamic range is equal to or wider than that
for the SMAC, except for BUN and Iron. Comparison of
linearity ofmethods for Olympus and the SMAC showed
that the Olympus had a wider range for triglycerides,
cholestrol, the enzymes, sodium and potassium. This
comparison appears in table 7.
Carry-over
Results of the carry-over experiment are summarized in
table 8. The amount of carry-over for sodium was
between 1"26 and 2"54% and that for potassium was
between 2"46 and 4"52%. Bicarbonate (3"77%) and
Table 6. Linear range ofmethods.
creatinine (4.46%), calcium (2’43%) and bilirubin
(5"33%) demonstrated a modest amount of carry-over.
All the other methods had less than 1% carry-over and
for some methods, i.e. glucose, ALT and BUN no
evidence of carry-over was found.
Correlation
For most methods, patient values agreed with those ofthe
SMAC II. Correlation coefficients above 0"900 were
obtained, except for chloride, bicarbonate and calcium.
For the latter, the range ofvalues was too small to obtain
a valid coefficient. The Olympus has the capability of
adjusting its values to bring them into agreement with
those obtained on another instrument. In this study,
these factors were not used. Application ofthe factors can
be made either before or after analysis is performed and
final results can be made to mimic those of the SMAC I1.
Throughput
The throughput achieved was 265 patient samples/hour
and takes into account the time devoted to the set up,
priming and calibration procedures required prior to
patient sampling. The instrument is capable ofachieving
a maximum throughput of 280 samples/hour following
Test Source Expected
Difference
Observed (%)
Glucose NERL
Sodium NERL
Potassium NERL
Chloride NERL
Bicarbonate NERL
BUN NERL
Creatinine NERL
Uric acid NERL
Calcium NERL
I. phosphorus NERL
T. protein NERL
50
200
750
100
130
160
2"0
4"0
8"0
70
100
130
5
25
40
10
50
70
1"0
7-0
15.0
4"0
8"0
12"0
5"0
10.0
15.0
1"0
5"0
10.0
2"0
6"0
10"0
51 2"00
207 3"50
767 2-27
103 3-00
132 1"54
160 0"00
2"O 0"00
4"O 0"00
7’8 -2"50
72 2-86
102 2"00
126 3"08
5 0"00
24 4"00
39 -2"50
9 10"00
5O 0"00
68 -2"86
1"0 0"00
7"0 0"00
15"0 0"00
4"2 5-0O
8"3 3"75
12"1 0"83
4.6 -8"O0
10"0 0-00
15"8 5"33
"0 0"00
5’ 2"00
10"3 3"00
2" 5-00
6.4 6"67
10"7 7"00
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these initial set-up procedures and assumes within-run
calibration and quality control procedures are performed
as required.
Discussion
The instrument is designed for high sample and test
throughput. The sample rate oftheAU 5061 is fixed. This
means that profiles offrom to 26 tests are performed at
the same rate. The rate claimed by Olympus is 300/hour.
The effective throughput taking into account start-up
routines is actually 200/hour for the first hour and a
maximum of 280/hour once the instrument is in full
operation. Patient throughput was found to be 265
samples/hour. Other instrumental approaches consider
test throughput rather than sample throughput. With the
Olympus, a conservative throughput of 265 patient
samples/hour and a maximum of 26 tests/sample gives a
test throughput of6890 tests/hour. This high throughput
makes some special requirements on the steps devoted to
specimen processing and data entry both prior to and
following analysis. It is imperative that data entry is
expedited and the flow of samples to the instrument
optimized. Interface to a host computer facilitates the
transfer of data.
The number of tests available on the AU 5061 is 26 and
includes the two analytes on the flame (Na/K). This
leaves 24 compared to 18 (20- Na/K) on the SMAC II.
The six available tests can be utilized effectively by
offloading procedures done either manually or on smaller
pieces of automated equipment. Additional savings in
personnel and laboratory supplies can be achieved in this
way. The software has a feature that provides objective
photometric readings for assessing the degree of lipemia,
icterus and hemolysis of the sample.
The instrument is fast. The throughput is two-and-a-half
to three times that ofthe SMAC II analyser. The limiting
factor is processing and essential data entry steps
required for getting specimens onto the instrument. The
linear range is wider in some cases which means fewer
repeats. The 700 mg/dl upper limit for triglycerides, for
instance, means that fewer repeats are required. Fewer
repeats adds to the cost savings that can be realized.
Table 6 continued.
Test Source Expected
Difference
Observed (%)
Albumin NERL
Bilirubin Pooled patient
Alk. phos. Sigma
LDH Sigma
AST Sigma
ALT Sigma
Cholesterol Pooled patient
Triglyceride Pooled patient
Iron NERL
GGT Pooled patient
CK Pooled patient
2"0 2"1 5"00
4"0 4"2 5"00
6"0 6"0 0.00
3"1 3"2 3"23
9"2 9"3 1"09
15"3 15"3 0"00
391 409 4’60
783 805 2"81
1174 1174 0"00
175 205 17.14
700 806 15.14
1750 1750 0"00
163 164 0.61
489 492 0.61
815 815 0"00
221 225 1.81
662 668 0"91
1104 1104 0’00
105 108 2"86
314 311 -0"96
524 524 0’00
205 219 6"83
411 412 0"24
821 821 0"00
5O 50 0"00
150 144 -4-00
3O0 285 -5"O0
113 112 -0.88
338 332 -178
564 564 0"00
204 219 7’35
613 613 0"00
1022 1022 0"00
NERL New England Reagent Laboratory.
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Temperature control for analytical measurements is
achieved with a dry bath which surrounds the cuvette
wheel. Coolant is circulated through an enclosed system
and gives a constant fixed reaction temperature of 37 +
0"2 C. Variation of the reaction temperature to 25C or
30C for enzyme measurements is not possible. The glass
reaction cuvette also serves as the measurement cuvette.
Up to eight photometric measurements are taken at two
wavelengths as the cuvettes advance. A series of fibre
Table 7. Stated dynamic ranges compared.
Test Olympus Units SMAC II
Albumin 6 g/dl 6
Alk. phos. 1500 U/1 750
ALT 500 U/1 500
Amylase 1000 U/1 N/A
AST 500 U/1 500
Bicarbonate 40 mEq/1 40
T. bilirubin 20 mg/dl 20
D. bilirubin 10 mg/dl N/A
BUN 120 mg/dl 150
Calcium 16"0 mg/dl 15
Chloride 140 mEq/1 70-130
Cholesterol 500 mg/dl 500
CK 1500 U/1 N/A
Creatinine 20"0 mg/dl 20
GGT 1500 U/1 500
Glucose 500 mg/dl 500
I. phosphorus 15"0 mg/dl 10
Iron 1000 ug/dl 1250
LD 2000 U/1 600
Magnesium 4"5 mEq/1 N/A
T. protein 15’0 g/dl 10
Triglyceride 700 mg/dl 500
Uric Acid 20"0 mg/dl 15
optics distribute the light from a single 100 W Halogen
source lamp. A single interference filter wheel and eight
photodiodes at each of the read stations completes the
optical system. A second reagent addition occurs after the
first reading for those methods such as the enzyme
measurements which may require it. Both end-point and
rate methods can be run and are selected by the
individual test parameters (see table 9). Delayed readings
can be specified for optimizing reaction rates for both
end-point and kinetic methods. The test parameters
include minimum and maximum absorbance values,
reagent blanks, quality control, linear range and refer-
ence range. Sample blanks can be run but this requires
devoting one of the available 24 tests to each blank
method. Thus 12 blanks can be run on the AU 5061,
together with 12 tests for a total of 24 available channels.
The amount ofreagent required for each determination is
in the range of250-500 tl which dramatically reduces the
cost of reagents compared to that required to operate
continuous-flow instruments. Table 9 summarizes
method parameters for the various procedures. In
addition, the cost of other consumables (pump tubing,
coils etc.) is eliminated. Expenses for AU5061 consum-
ables other than reagents include pump tubes to operate
the flame, sample cups, and bar code labels. Other items
would include reagent tubing, sample probes, and
reaction cuvettes. During the brief 60-day evaluation
period, none of the latter items needed replacement.
Approximately 80 ft of floor space are required for
installation and operation. Electrical requirements
include 220 V (+ 10%), 50/60 Hz (+1 Hz), single phase
grounded outlet. Other physical requirements include a
floor drain, a source of deionized water capable of
Table 8. An analysis ofcarry-over.
Random Carry-over Carry-over Random Carry-over Carry-over
Test mean mean (percentage) mean mean (percentage)
Glucose 80.5 80.5 0.00 265"2 265.2 0.15
Sodium 151"2 149.3 1.26 118 121 2"54
Potassium 6"9 6"7 -2"46 3"98 4.16 4’52
Chloride 106" 105"8 -0"28 84"5 85"0 0’59
Bicarbonate 23’9 24’8 3’77 18.5 18"5 0"00
BUN 15"8 15"8 0"00 50"8 50"6 -0"39
Creatinine 1.12 1"07 -4’46 6’03 6.14 1"82
Uric acid 5"27 5"29 0"38 10"43 10"45 0" 192
Calcium 9"47 9"70 2"43 13’45 13"44 -0"07
Phosphorus 2’91 2"89 -0"69 6"95 6"98 0"43
T. protein 7"30 7"31 0"14 5"41 5"40 -0"19
Albumin 4"30 4"32 0.47 3’40 3.39 -0"29
Bilirubin 1.50 1.58 5"33 5"87 5"81 1"02
Alk. phos. 52"9 52"7 -0"38 246"6 244"8 -0"73
LDH 107"4 105"6 1"68 339"7 343"5 1"12
AST 35"5 35"7 0"56 157.2 155’7 -0"95
ALT 20"0 20"0 0"00 121"7 120"4 1"07
Cholesterol 237’8 238"8 0"42 121"5 121’3 -0"17
Triglyceride 82"1 82"6 0"61 175.3 174.0 -0’74
Iron 234" 232"5 -0"68 104"5 105"5 0"96
GGT 17" 16"9 1" 17 74’5 74"9 0"54
CK 171"2 169.9 -0"76 605"4 605"3 -0"02
Defined in the study as the amount of high (or low) control carried-over to a low (or high) control sample and expressed as a
percentage.
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delivering 60 l/h, and a supply ofpropane gas to operate
the flame photometer.
Deionized water is required for blanking and washing the
cuvettes. The water is de-gassed within the system to
prevent air bubbles developing in any of the lines. The
pumps required for this purpose create a certain amount
of noise when they are in operation. However, they are
shielded and the noise level was not considered a serious
concern.
Test requisitions can be created on the system for up to
4000 patient specimens. This can be performed either
before, during (STATs) or after the analyser is opera-
Table 9. Method parameters.
tinal. Single tests or panels can be requisitioned for one
sample (STATS) at a time or for groups of samples
(batching). A work list is printed for the tests to be run.
The instrument uses a sample number to indicate the
order entry of the requisition and ties to it an accession or
patient’s identification number. Pre-defined panels are
then requisitioned by a panel code number. Although
these features are available, the high throughput of this
instrument requires an interface program to a host
computer to facilitate data transfer. Downloading of
those key elements required to do the test (tests ordered,
instrument ID, etc.) is necessary to optimize the work-
flow. A simulation of this was tried with a personal
Sample Reagent
Test volume (tl) volume (tl) Method
Wavelength: Reference
(nM) values
Albumin 3
Alk. phos. 4
ALT l0
Amylase 6
AST 10
D. bilirubin 15
T. bilirubin 15
Bicarbonate 4
Calcium 3
Chloride 3
Cholesterol 3
HDL-cholesterol 12
CK 5
Creatinine 15
300 EP
250 Rate
200/50 Rate
250 Rate
200/50 Rate
250/100 EP
250 EP
250/75 EP
125/125 EP
250 EP
300 EP
300 EP
250 Rate
250/125 EP
600/750 3"5-5"0 g/dl
410/520 M: 30-125 U/1
F: 20-115 U/1
340/410 5-30 U/1
410/520 25-125 U/1
340/410 0-34 U/1
540/660 0"0-0"35 mg/dl
540/660 0" 1-1"5 mg/dl
380/410 22-33 mEq/1
570/600 8"4.10"2 mg/dl
520/600 98-106 mmol/1
520/750 140-310 mg/dl
520/750 M 26-63 mg/dl
F 33-75 mg/dl
340/520 M 38-174 U/1
F :26-140 U/1
520/600 M :0"7-1"3 mg/dl
F :0"6-1 "2 mg/dl
Reagent 1/Reagent 2 when more than one reagent is used.
EP Endpoint; Rate Kinetic method, usually with 3-6 readings.
Primary/secondary wavelength for bichromatic analysis.
Table 9 continued.
Sample Reagent
Test volume (1) volume (tl) Method
Wavelength Reference
(nM) values
GGT 5 125/125 Rate
Glucose 3 300 EP
Iron 15 250/150 EP
I. phosphorus 6 250/50 EP
LD 5 250 Rate
Magnesium 3 150/150 EP
T. protein 4 250 EP
Triglyceride 3 250/50 EP
BUN 3 200/50 EP
Uric acid 6 250/50 EP
Sodium 50 N/A ES
Potassium * N/A ES
410/520 M: 5-38 U/1
F: 5-29 U/1
340/380 70-105 mg/dl
600/750 M: 70-180 ug/dl
F: 60-180 ug/dl
340/380 2"5-4"5 mg/dl
340/410 100-225 U/1
520/750 1"3-2" mEq/l
540/660 6"4-8"3 g/dl
540/600 M: 40-160 mg/dl
F: 35-135 mg/dl
340/410 7-18 mg/dl
520/600 M: 3"5-7"2 mg/dl
F: 2"6-6"0 mg/dl
589 136-146 mEq/1
768 3"5-5"0 mEq/1
Reagent 1/Reagent 2 when more than one reagent is used.
EP Endpoint; Rate Kinetic method, usually with 3-6 readings; ES Emission Spectra.
Primary/secondary wavelength for bichromatic analysis.
* Same sample as sodium.
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computer and the bi-directional interface in the Olympus
software was found to function according to specifica-
tions.
Correlation with SMAC II values was acceptable. The
Olympus software has the capacity ofadjusting its values
to bring them into agreement with those obtained on the
SMAC II. Adjustments can be made either before or after
the tests are run and, for the latter, as a batch process.
Reference values as supplied by Olympus are found in
table 9 and differ from those standardized and employed
by SKBL.
Calibration of the Olympus was conducted using SMAC
reference sera. A calibrator supplied by Olympus was
judged to be unacceptable. Definition of the number of
calibrator and control samples is required. It is clearly
different from that required for the SMAC II operation.
Calibration is stable for up to h for the flame, 2-3 h for
bicarbonate, and 6-8 h for other chemistries. The
stability of the instrument indicates that quality control
checks may only be required every 300 patient samples.
Considerable savings in quality-control material can thus
be achieved with this instrument.
Reagents are stored in refrigerated compartments above
the analytical components. The bottle size supplied was
considered too small for high volume use. The container
size should be increased four fold to accommodate 2 for
most chemistries. Checks on the existing reagent volumes
are a part of the start-up protocol and this information is
available through the CRT.
Maintenance is relatively simple to perform. The items
requiring attention include the pump tubes on the flame.
These should be replaced once a week. Weekly and
monthly maintenance requires 30-40 min in each case.
Every three months the conveyor belt and water tank
need to be cleaned and this takes approximately 2 h to
complete. The evaluation revealed that additional main-
tenance was required for the calcium, chloride and
bicarbonate methods. This requires approximately 20
min/day and involves a cleaning of the reagent lines. The
sample probe can become clogged with fibrin clots and
must be visually inspected during operation. The instru-
ment performs a forced flush with deionized water
between samples which helps to minimize this occur-
rence. Additionally, time must be devoted to preparing
the samples which includes filtering all samples. Replace-
ment of the sample probe is not difficult. The sample
probe is a vital link. Since each module contains its own
probe, a malfunction in one probe effects only the four
tests on that module.
The computer system offers only rudimentary quality-
control features. This function is better handled using
more sophisticated programs available on a laboratory
host computer. The options available include calcula-
tions for standard deviation, mean, and coefficient of
variation. It will not allow elimination of outliers, and
editing of QC data is not easily performed. It does
provide Qc charts for each test and each control
individually, but decision-making trees and summary
reports are not included.
The instrument for evaluation was not interfaced to the
laboratory computer. Testing of the bi-directional inter-
face using a PC indicated that it did perform as specified
by Olympus. The conclusion reached was that an
interfaced program could be written and interfaced to the
SKBL host computer system.
The bar-code reading device was not functional with the
labels supplied. A source of bar-code labels was obtained
and the labels were placed on the rack instead of the
tubes. This allows for the re-use of the label and was
considered a better approach than placing it on the tube.
The instrument requires entry of specimen identification
before analysis is performed. The Olympus defaults to
not doing any tests but only for that particular sample. As
a result, the instrument does not stop completely if a
patient identification has not been entered. It will
continue to analyse the other specimens that have been
entered.
Olympus has indicated that the current software pro-
grams are to be enhanced with special packages for
quality control, result verification using a multi-variate
alogorithm and management reporting. The calculated
parameters available at this time are A (B), (A-B)/A, A/B
and A/(B-A). It does not permit, for instance, the
calculation of an ionized calcium. The bar code reading
device worked with the code-a-bar (European) format. It
uses an LED device and has the advantage that it does
not have any moving parts. Olympus has indicated
further that a dial-up capability for diagnostics will be
offered.
Training is easily accomplished. Operator proficiency
can be achieved in a shorter period than that required to
operate a SMAC II. The instrument is menu driven by
the CRT and is easy to follow. Help screens are not a part
of the software program, however. Trouble shooting is
easier to perform using a much improved and updated
operator’s manual.
Conclusion
The instrument did not have any serious problems during
the 60-day evaluation period that caused it to be down.
Overall, the Olympus AU5061 was judged to be an
effective replacement for the SMAC II instrument
providing advantages in increased throughput with
significant reductions in operating expenses.
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